Credit: Getty Images For Unsplash+
In A Nutshell
- Women who had three or more children had about half the stroke risk of women who never gave birth, based on nearly two decades of follow-up data.
- Higher birth count was also linked to roughly 48% lower odds of “silent” strokes, areas of brain damage that show up on scans but often cause no obvious symptoms.
- Researchers think repeated estrogen surges during pregnancy may condition blood vessels in ways that reduce stroke risk, but this is a hypothesis and was not directly tested.
- This is an observational study, so it cannot prove that having children prevents strokes; doctors may still want to factor reproductive history into how they assess women’s stroke risk.
Women who gave birth to three or more children had about half the stroke risk of women who never gave birth, according to a long-running study tracking nearly 1,900 women over almost two decades. That association held up even after researchers accounted for known stroke risk factors like high blood pressure, diabetes, and smoking. To be clear, this does not mean having more children prevents strokes. It is an association, and one that researchers say warrants a harder look at how doctors assess women’s stroke risk.
Stroke already hits women harder than men. According to the study authors, 57% of all strokes in the United States occur in women, and projections suggest an additional 68,000 stroke deaths per year among women by 2050. Yet most stroke prediction tools don’t factor in a woman’s reproductive history. That gap in standard care is what this research, published in the Journal of the American Heart Association, was designed to address, though results may not apply equally across all racial and ethnic groups, since the study population was predominantly White.
Three or More Births Linked to Lower Stroke Risk
Beyond clinical strokes, women with three or more live births were also about 48% less likely to have so-called “silent” strokes, small areas of brain damage visible on MRI scans that often go unnoticed by the patient. These can accumulate over time and contribute to cognitive decline and dementia, making them as clinically significant as the more dramatic variety.
Researchers analyzed data from 1,882 women enrolled in the Framingham Heart Study Offspring cohort, all confirmed stroke-free at enrollment between 1998 and 2001. Average age at baseline was 61, and women were followed for a median of roughly 18 years. During that period, 126 women had a stroke.
At the outset, participants reported their reproductive histories through questionnaires, detailing how many children they had given birth to, when they went through menopause, and whether they had used hormone replacement therapy. Researchers also measured blood estrogen levels from fasting morning blood samples. Women were divided into three groups: no live births (the comparison group), one to two, and three or more.

What the Numbers Showed
Women with three or more live births had a 49% lower risk of stroke compared to women with no live births. Women with one or two births showed a trend toward lower risk as well, but that difference wasn’t large enough to be statistically definitive.
In a separate brain-scan analysis of 1,165 dementia-free women, those with three or more live births were 48% less likely to have silent brain damage compared to women who had never given birth.
None of the other reproductive factors examined, including age at menopause, estrogen blood levels, and hormone replacement therapy use, showed a meaningful connection to stroke risk after adjusting for cardiovascular risk factors. Number of live births was the only reproductive factor that showed a significant association in this analysis.
Why the Link Exists Remains an Open Question
Researchers offered possible explanations, though none were directly tested in this study. One leading theory centers on estrogen: during each pregnancy, a woman’s body sustains elevated estrogen levels over nine months. Lab research has shown estrogen has protective effects on blood vessel walls and improves blood flow to the brain. Animal studies suggest that extended periods of high estrogen exposure may cause lasting improvements to how blood vessels function, essentially conditioning the circulatory system in ways that could carry protective benefits well into later life.
Another possibility is that more live births may reflect lower rates of infertility and miscarriage, both of which are independently linked to higher stroke risk. Women with more children may also have spent less cumulative time on hormonal birth control, which has its own complicated relationship with stroke risk, though the researchers lacked reliable contraceptive data to test that idea. Unmeasured factors, including income, marital status, social support, and health behaviors during pregnancy, could also account for some or all of the observed pattern.
What Doctors Might Do With This
The study has limitations. Beyond its predominantly White population, researchers lacked data on pregnancy complications like gestational diabetes or preeclampsia, both of which affect estrogen exposure and stroke risk. Brain scans were available only at one point in time rather than before and after pregnancies, so reverse causation cannot be fully ruled out for those findings. And as an observational study, it cannot establish that childbirth itself is directly responsible for any reduction in stroke risk.
Stroke already disproportionately affects women, and current prediction tools largely ignore their reproductive histories. If something as straightforward as birth count turns out to carry meaningful information about who is most at risk, that is worth knowing.
Disclaimer: This article is based on published scientific research and is intended for informational purposes only. It is not intended as medical advice. Consult a qualified healthcare professional before making any decisions related to your health.
Paper Notes
Limitations
Several limitations apply. The study population was predominantly White European American, which may limit how broadly these results apply to women of other racial and ethnic backgrounds. Researchers did not have data on pregnancy complications such as gestational diabetes, gestational hypertension, or preeclampsia, which can affect estrogen exposure and stroke risk. Data on miscarriages was also unavailable. Reliable information on oral contraceptive use and on the timing, type, and duration of hormone replacement therapy was not available, preventing deeper analysis of those factors. Serum estrogen levels were measured at only one time point rather than across the reproductive lifespan. Brain imaging was only available at a single time point and not at baseline, meaning reverse causation for the brain scan findings cannot be fully ruled out. Several potentially important unmeasured confounders, including socioeconomic status, income, marital status, religiosity, social support, healthy lifestyle behaviors during pregnancy, and breastfeeding duration, were not accounted for. Results were not adjusted for multiple testing. Small numbers of women with higher-order births prevented exploration of a dose-response relationship beyond the categories used.
Funding and Disclosures
This research was supported by the Health Research Board of Ireland (Clinician Scientist Fellowship, CSF-2020-011). The Framingham Heart Study is supported by the National Heart, Lung, and Blood Institute (Contract No. N01-HC-25195, No. HHSN268201500001, and No. 75N92019D00031). Additional support came from National Heart, Lung, and Blood Institute grants R01 HL60040 and R01 HL70100; National Institute on Aging grants R01 AG054076, R01 AG049607, P30 AG066546, R01 AG066524, RF1 AG059421, U19 NS120384, and P30 AG072972; National Institute of Diabetes, Digestive, and Kidney Diseases grant R01DK092938; and National Institute of Neurological Disorders and Stroke grants NS017950 and UF1 NS125513. No funding entities had any role in the study’s design, conduct, analysis, interpretation, or publication decisions. Authors reported no conflicts of interest. Dr. McGrath had full access to all data and takes responsibility for its integrity and the data analysis.
Publication Details
Title: Number of Live Births as a Protective Factor Against Clinical and Covert Brain Infarcts: The Framingham Heart Study | Authors: Senan Maher, Matthew R. Scott, Rachel F. Buckley, Charles S. DeCarli, Hugo J. Aparicio, Jose Rafael Romero, Ramachandran S. Vasan, Joanne M. Murabito, Shalender Bhasin, Alexa S. Beiser, Sudha Seshadri, and Emer R. McGrath (joint senior authors: Sudha Seshadri and Emer R. McGrath) | Journal: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | DOI: 10.1161/JAHA.125.044037 | Affiliations include: School of Medicine, University of Galway, Ireland; The Framingham Heart Study, Framingham, MA; Department of Biostatistics, Boston University Chobanian & Avedisian School of Public Health; Department of Neurology, Massachusetts General Hospital and Harvard Medical School; Department of Neurology, University of California, Davis; Department of Neurology, Boston University Chobanian & Avedisian School of Medicine; University of Texas Health Science Center, San Antonio; Research Program in Men’s Health, Aging and Metabolism, Brigham and Women’s Hospital, Harvard Medical School; Glenn Biggs Institute for Alzheimer’s & Neurodegenerative Diseases, University of Texas Health Sciences Center; and HRB Clinical Research Facility, University of Galway, Ireland. | Received: May 29, 2025; Accepted: August 18, 2025 | Correspondence: Emer R. McGrath, School of Medicine, University of Galway, Ireland







